These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24632034)

  • 1. Preparation and optimization of voriconazole microemulsion for ocular delivery.
    Kumar R; Sinha VR
    Colloids Surf B Biointerfaces; 2014 May; 117():82-8. PubMed ID: 24632034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation development, in vitro and in vivo evaluation of microemulsion-based gel loaded with ketoprofen.
    Nikumbh KV; Sevankar SG; Patil MP
    Drug Deliv; 2015; 22(4):509-15. PubMed ID: 24266589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucoadhesive chitosan-coated cationic microemulsion of dexamethasone for ocular delivery: in vitro and in vivo evaluation.
    Kesavan K; Kant S; Singh PN; Pandit JK
    Curr Eye Res; 2013 Mar; 38(3):342-52. PubMed ID: 23216079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro and in-vivo comparison of T-OA microemulsions and solid dispersions based on EPDC.
    Hou P; Cao S; Ni J; Zhang T; Cai Z; Liu J; Wang Y; Wang P; Lei H; Liu Y
    Drug Dev Ind Pharm; 2015 Feb; 41(2):263-71. PubMed ID: 24256156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel ofloxacin-loaded microemulsion formulations for ocular delivery.
    Üstündag-Okur N; Gökçe EH; Eğrilmez S; Özer Ö; Ertan G
    J Ocul Pharmacol Ther; 2014 May; 30(4):319-32. PubMed ID: 24367973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terpene microemulsions for transdermal curcumin delivery: effects of terpenes and cosurfactants.
    Liu CH; Chang FY; Hung DK
    Colloids Surf B Biointerfaces; 2011 Jan; 82(1):63-70. PubMed ID: 20828994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase Transition Microemulsion of Brimonidine Tartrate for Glaucoma Therapy: Preparation, Characterization and Pharmacodynamic Study.
    Gautam N; Kesavan K
    Curr Eye Res; 2021 Dec; 46(12):1844-1852. PubMed ID: 34176380
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of cyclosporine A microemulsion for parenteral delivery.
    Yuan Y; Che X; Zhao M; Wang Y; Liu Y; Schwendeman A; Li S
    J Microencapsul; 2015; 32(3):273-80. PubMed ID: 25761521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of surfactant/cosurfactant synergism impact on ibuprofen solubilization capacity and drug release characteristics of nonionic microemulsions.
    Djekic L; Primorac M; Filipic S; Agbaba D
    Int J Pharm; 2012 Aug; 433(1-2):25-33. PubMed ID: 22579578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microemulsions as potential ocular drug delivery systems: phase diagrams and physical properties depending on ingredients.
    Radomska-Soukharev A; Wojciechowska J
    Acta Pol Pharm; 2005; 62(6):465-71. PubMed ID: 16583987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies.
    Sintov AC; Levy HV; Botner S
    J Control Release; 2010 Dec; 148(2):168-76. PubMed ID: 20709120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous delivery of econazole using microemulsion as vehicle: formulation, evaluation and vesicle-skin interaction.
    Ge S; Lin Y; Lu H; Li Q; He J; Chen B; Wu C; Xu Y
    Int J Pharm; 2014 Apr; 465(1-2):120-31. PubMed ID: 24530389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro, ex vivo, and in vivo evaluation of the effect of saturated fat acid chain length on the transdermal behavior of ibuprofen-loaded microemulsions.
    Ren Q; Deng C; Meng L; Chen Y; Chen L; Sha X; Fang X
    J Pharm Sci; 2014 Jun; 103(6):1680-91. PubMed ID: 24700251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of antitubercular drug isoniazid in pharmaceutically accepted microemulsion: effect on microstructure and physical parameters.
    Mehta SK; Kaur G; Bhasin KK
    Pharm Res; 2008 Jan; 25(1):227-36. PubMed ID: 17577642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved efficacy of fluconazole against candidiasis using bio-based microemulsion technique.
    Nirmala MJ; Mukherjee A; Chandrasekaran N
    Biotechnol Appl Biochem; 2013; 60(4):417-29. PubMed ID: 23586695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase-transition W/O Microemulsions for Ocular Delivery: Evaluation of Antibacterial Activity in the Treatment of Bacterial Keratitis.
    Bharti SK; Kesavan K
    Ocul Immunol Inflamm; 2017 Aug; 25(4):463-474. PubMed ID: 26943481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cremophor RH40-PEG 400 microemulsions as transdermal drug delivery carrier for ketoprofen.
    Ngawhirunpat T; Worachun N; Opanasopit P; Rojanarata T; Panomsuk S
    Pharm Dev Technol; 2013; 18(4):798-803. PubMed ID: 22023398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of formulation components on the in vitro permeation of microemulsion drug delivery system of fluconazole.
    Patel MR; Patel RB; Parikh JR; Solanki AB; Patel BG
    AAPS PharmSciTech; 2009; 10(3):917-23. PubMed ID: 19609836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase behavior of the microemulsions and the stability of the chloramphenicol in the microemulsion-based ocular drug delivery system.
    Lv FF; Zheng LQ; Tung CH
    Int J Pharm; 2005 Sep; 301(1-2):237-46. PubMed ID: 16039810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of microemulsions as prolonged-release injectables through in-situ phase transition.
    Wu Z; Alany RG; Tawfeek N; Falconer J; Zhang W; Hassan IM; Rutland M; Svirskis D
    J Control Release; 2014 Jan; 174():188-94. PubMed ID: 24316265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.